Abstract
Graphical representations of DNA sequences is a new field of analysis of the DNA and RNA sequences that have the potential to be of utility in determination of drug-DNA interaction sites and also yield indexation schemes to quantify levels of potency or toxicity of various chemicals and drugs. In this paper we explain the new techniques of analysis and briefly review some of the applications that have been made relevant to the field of drug design and chemical toxicity measures specifically in relation to DNA and RNA sequences. The review concludes with some remarks on the future directions that could be taken in development and applications of this nascent technique.
Keywords: Numerical characterization, Graphical representation, base distribution characteristics, DNA sequence, drug design, drug-DNA interface, chemical toxicity, toxicity indexes, DNA replication, transcription, maintenance, proliferation, non-promoter sequences, thermodynamic, kinetic characteristics of the interactions, structure-activity relationship models, nuclear magnetic resonance, light scattering experiments, computational techniques, screening of new DNA binding drugs, exonuclease digestion, carbazole dications, DNA minor groove, lock-andkey, rational drug design, microRNAs, non-protein-coding RNAs, colon cancer, biomarker research, Quantitative structure-activity relationships (QSAR), quantitative structure-property relationships (QSPR), binding affinities, stable ring-structure, anti-tumour activity, mutant strains, pathogenic organisms, drug-resistant pathogens, The Open Source Drug Discovery (OSDD), genetic, biological information, 3D model, RNA secondary structures, phylogenetic studies, proteomics studies, Cartesian coordinate system, cytosine, nucleotides, “worm” curve, spectrum-like, 2D approach, bio-descriptors, accidental degeneracy, base mutations, exon sequence, beta-globin gene, nucleotide sequences, antibiotics, human diseases, Acute Respiratory Syndrome, coronavirus, generate phylogenetic, multiple alignments, mouse chromosomal sequences, protein serum profiles, interaction, neuraminidase inhibitors, target macromolecule, Ligand, Macromolecule, integrated QSAR, Viral genomes, Phylogenetic relationships, hydrophobic chemical group, polar chemical group, phylogenetic tree, avian flu strains, neuraminidase gene, convex blob linked, hemagglutinin type, influenza genomes, pandemic
Current Computer-Aided Drug Design
Title: New Approaches to Drug-DNA Interactions Based on Graphical Representation and Numerical Characterization of DNA Sequences
Volume: 6 Issue: 4
Author(s): Ashesh Nandy and Subhash C. Basak
Affiliation:
Keywords: Numerical characterization, Graphical representation, base distribution characteristics, DNA sequence, drug design, drug-DNA interface, chemical toxicity, toxicity indexes, DNA replication, transcription, maintenance, proliferation, non-promoter sequences, thermodynamic, kinetic characteristics of the interactions, structure-activity relationship models, nuclear magnetic resonance, light scattering experiments, computational techniques, screening of new DNA binding drugs, exonuclease digestion, carbazole dications, DNA minor groove, lock-andkey, rational drug design, microRNAs, non-protein-coding RNAs, colon cancer, biomarker research, Quantitative structure-activity relationships (QSAR), quantitative structure-property relationships (QSPR), binding affinities, stable ring-structure, anti-tumour activity, mutant strains, pathogenic organisms, drug-resistant pathogens, The Open Source Drug Discovery (OSDD), genetic, biological information, 3D model, RNA secondary structures, phylogenetic studies, proteomics studies, Cartesian coordinate system, cytosine, nucleotides, “worm” curve, spectrum-like, 2D approach, bio-descriptors, accidental degeneracy, base mutations, exon sequence, beta-globin gene, nucleotide sequences, antibiotics, human diseases, Acute Respiratory Syndrome, coronavirus, generate phylogenetic, multiple alignments, mouse chromosomal sequences, protein serum profiles, interaction, neuraminidase inhibitors, target macromolecule, Ligand, Macromolecule, integrated QSAR, Viral genomes, Phylogenetic relationships, hydrophobic chemical group, polar chemical group, phylogenetic tree, avian flu strains, neuraminidase gene, convex blob linked, hemagglutinin type, influenza genomes, pandemic
Abstract: Graphical representations of DNA sequences is a new field of analysis of the DNA and RNA sequences that have the potential to be of utility in determination of drug-DNA interaction sites and also yield indexation schemes to quantify levels of potency or toxicity of various chemicals and drugs. In this paper we explain the new techniques of analysis and briefly review some of the applications that have been made relevant to the field of drug design and chemical toxicity measures specifically in relation to DNA and RNA sequences. The review concludes with some remarks on the future directions that could be taken in development and applications of this nascent technique.
Export Options
About this article
Cite this article as:
Nandy Ashesh and C. Basak Subhash, New Approaches to Drug-DNA Interactions Based on Graphical Representation and Numerical Characterization of DNA Sequences, Current Computer-Aided Drug Design 2010; 6 (4) . https://dx.doi.org/10.2174/1573409911006040283
DOI https://dx.doi.org/10.2174/1573409911006040283 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Emerging Role of TRP Channels in Mechanisms of Temperature and Pain Sensation
Current Neuropharmacology Biomedical Technologies for In Vitro Screening and Controlled Delivery of Neuroactive Compounds
Central Nervous System Agents in Medicinal Chemistry Recent Progress and Challenges in Nanotechnology for Biomedical Applications: An Insight into the Analysis of Neurotransmitters
Recent Patents on Nanotechnology HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews Novel Methods for the Non-Invasive Administration of DNA Therapeutics and Vaccines
Current Drug Delivery Multiscale Mapping of AIDS in U.S. Countries vs Anti-HIV Drugs Activity with Complex Networks and Information Indices
Current Bioinformatics Rational Basis for Nutraceuticals in the Treatment of Glaucoma
Current Neuropharmacology Understanding the Role of Aldose Reductase in Ocular Inflammation
Current Molecular Medicine Placental Drug Disposition and Its Clinical Implications
Current Drug Metabolism Current and Promising Therapies in Autosomal Recessive Ataxias
CNS & Neurological Disorders - Drug Targets Progress in the Development of Bestatin Analogues as Aminopeptidases Inhibitors
Current Medicinal Chemistry Signaling Pathways Involved in Antidepressant-Induced Cell Proliferation and Synaptic Plasticity
Current Pharmaceutical Design Prophylaxis of Cancer
Current Cancer Therapy Reviews HIV / SIV Escape from Immune Surveillance: Focus on Nef
Current HIV Research Prodigiosins as Anti Cancer Agents: Living Upto Their Name
Current Pharmaceutical Design The Purinome, a Complex Mix of Drug and Toxicity Targets
Current Topics in Medicinal Chemistry Chaperone-like Activity of alpha-Crystallin and Other Small Heat Shock Proteins
Current Protein & Peptide Science Strategies for Antimicrobial Drug Delivery to Biofilm
Current Pharmaceutical Design Using an Ancient Tool for Igniting and Propagating Immune Tolerance: IDO as an Inducer and Amplifier of Regulatory T Cell Functions
Current Medicinal Chemistry Common Mechanisms of Excitatory and Inhibitory Imbalance in Schizophrenia and Autism Spectrum Disorders
Current Molecular Medicine